May 15, 2012
MD247 announced the launch of its LinkedIn supplemental telemedicine discussion group on Monday morning. The LinkedIn discussion group was launched to foster discussion regarding the field of supplemental telemedicine, garner product reviews and build a community of small and large business owners looking to positively enhance the face of healthcare for their employees. The MD247 telemedicine team explained that people are the key component in ANY healthcare program, and MD247 needed to create a group where everyone felt comfortable contributing to the discussion.
The MD247 LinkedIn discussion group is open for membership by clicking here. Members of the LinkedIn telemedicine discussion group can share best practices, suggestions for enhancing the product, questions and read about the latest news from the team behind MD247.
LinkedIn is a business-related social networking site. Founded in December 2002 and launched in May 2003, LinkedIn is mainly used for professional networking between businesses. LinkedIn has more than 135 million registered users in more than 200 countries and territories. The site is available in English, French, German, Italian, Portuguese, Spanish, Romanian, Russian, Turkish and Japanese. LinkedIn has 21.4 million monthly unique United States based visitors and 47.6 million visitors globally. The LinkedIn website allows registered users to maintain a list of contact details of people with whom they have some level of relationship.
Largo Florida based MD247.COM (MD247; MD/247; MD 247; M.D.247; MD-247) provides an affordable telemedicine supplement to existing healthcare services. MD247.COM telemedicine program members have unlimited telephone access to a nationwide medical support team, all with just a single phone call to the MD247.COM telemedicine Talk to a Doctor/Talk to a Nurse Hotline. MD247.COM has a virtual platoon of registered nurses; board certified physicians and a support staff available to members for all non-emergency situations. More information about MD247.COM is available online at http://www.md247.com.
For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2012/5/prweb9503795.htm